Search
for
Sort by
Research 301–330 of 1000+
- Human keratinocytes derived from the bulge region of hair follicles are refractory to differentiation
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- A Clinical Evaluation of Guduchi (Tinospora cordifolia) and Yashtimadhu (Glycyrrhiza glabra) as Chemopreventive Agent in Cancer Treatment
- KERATIN PHENOTYPES IN BASAL-CELL CARCINOMAS OF THE SKIN
- Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling
- The sternum reconstruction: Present and future perspectives
- Severe Refractory Scarring Alopecia Associated With Combinational Use of Ficlatuzumab (AV-299) and Gefitinib
- Three Considerations Before Advising 5-α-Reductase Inhibitors for Chemoprevention
- Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients
- Mechanism of Targeting the Hedgehog Signaling Pathway against Chemotherapeutic Resistance in Multiple Myeloma
- Taxane-induced alopecia: A historical review of patients with ovarian or breast cancer treated with with paclitaxel, docetaxel or paclitaxel poliglumex
- Incidence of alopecia in brain tumour patients treated with pencil scanning proton therapy and validation of existing NTCP models
- Nano-pulse stimulation™ therapy (NPS™) is superior to cryoablation in clearing murine melanoma tumors
- Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part III on Psychosexual Therapy and the Masculine Self-Esteem)
- CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients.
- Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female
- A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor
- Off-label prescriptions: patient safety first
- Zinc deficiency is associated with gynecologic cancer recurrence
- The potential impact of melanosomal pH and metabolism on melanoma
- Scalp-sparing total skin electron therapy in mycosis fungoides: Case report highlighting technique and outcome
- Hair, Hormones, and High-Risk Prostate Cancer
- Care for alopecia during chemotherapy of cancer patients
- Hair loss as a consequence of cancer chemotherapy – physical methods of prevention. A review of the literature
- Abnormal hair growth in patients (pts) with metastatic colorectal cancer (mCRC) treated with the anti-epidermal growth factor receptor (EGFr) monoclonal antibody (mAb) panitumumab (Pmab)
- Absence of chemotherapy-induced alopecia with paclitaxel in a case of hypothyroidism: case report
- Eyelash trichomegaly complicating pembrolizumab for colorectal cancer
- Mild oxidative stress protects against chemotherapy-induced hair loss
- 532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011)